Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2003 1
2007 1
2016 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Innovation in the pharmaceutical industry: New estimates of R&D costs.
DiMasi JA, Grabowski HG, Hansen RW. DiMasi JA, et al. J Health Econ. 2016 May;47:20-33. doi: 10.1016/j.jhealeco.2016.01.012. Epub 2016 Feb 12. J Health Econ. 2016. PMID: 26928437
The price of innovation: new estimates of drug development costs.
DiMasi JA, Hansen RW, Grabowski HG. DiMasi JA, et al. J Health Econ. 2003 Mar;22(2):151-85. doi: 10.1016/S0167-6296(02)00126-1. J Health Econ. 2003. PMID: 12606142
Economics of new oncology drug development.
DiMasi JA, Grabowski HG. DiMasi JA, et al. J Clin Oncol. 2007 Jan 10;25(2):209-16. doi: 10.1200/JCO.2006.09.0803. J Clin Oncol. 2007. PMID: 17210942 Review.
Cost of innovation in the pharmaceutical industry.
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. J Health Econ. 1991 Jul;10(2):107-42. doi: 10.1016/0167-6296(91)90001-4. J Health Econ. 1991. PMID: 10113009
Feedback